abstract |
The present invention provides a novel method for administering anti-CD3 antibodies, such as by oral or transmucosal delivery. The present invention also provides a method for treating or preventing or delaying the onset of autoimmune diseases by oral or transmucosal administration of an anti-CD3 antibody. Finally, the present invention provides an anti-CD3 containing composition suitable for oral or transmucosal administration. |